Skip to main content
. Author manuscript; available in PMC: 2012 Feb 1.
Published in final edited form as: Toxicol Appl Pharmacol. 2010 Nov 25;250(3):221–228. doi: 10.1016/j.taap.2010.11.010

Fig. 1.

Fig. 1

Strategy and experimental design to define the mechanisms for differential surface expression ability and NCA binding activity between β1 and β3 subunits.